|
|
Blood, 1 April 2004, Vol. 103, No. 7, pp. 2504-2512.
Prepublished online as a Blood First Edition Paper on December 4, 2003; DOI 10.1182/blood-2003-07-2563.
 Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
VEGF-A165 augments erythropoietic development from human embryonic stem cells
Chantal Cerdan,
Anne Rouleau, and
Mickie Bhatia
From the Robarts Research Institute, Stem Cell Biology and Regenerative Medicine, and the Departments of Microbiology and Immunology and Physiology, The University of Western Ontario, London, ON, Canada.
Combinations of hematopoietic cytokines and the ventral mesoderm inducer BMP-4 have recently been shown to augment hematopoietic cell fate of human embryonic stem cells (hESCs) during embryoid body (EB) development. However, factors capable of regulating lineage commitment of hESC-derived hematopoiesis have yet to be reported. Here we show that vascular endothelial growth factor (VEGF-A165) selectively promotes erythropoietic development from hESCs. Effects of VEGF-A165 were dependent on the presence of hematopoietic cytokines and BMP-4, and could be augmented by addition of erythropoietin (EPO). Treatment of human EBs with VEGF-A165 increased the frequency of cells coexpressing CD34 and the VEGF-A165 receptor KDR, as well as cells expressing erythroid markers. Although fetal/adult globins were unaffected, VEGF-A165 induced the expression of embryonic zeta ( ) and epsilon ( ) globins, and was accompanied by expression of the hematopoietic transcription factor SCL/Tal-1. In addition to promoting erythropoietic differentiation from hESCs, the presence of VEGF-A165 enhanced the in vitro self-renewal potential of primitive hematopoietic cells capable of erythroid progenitor capacity. Our study demonstrates a role for VEGF-A165 during erythropoiesis of differentiating hESCs, thereby providing the first evidence for a factor capable of regulating hematopoietic lineage development of hESCs.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
Y. Yokoyama, T. Suzuki, M. Sakata-Yanagimoto, K. Kumano, K. Higashi, T. Takato, M. Kurokawa, S. Ogawa, and S. Chiba
Derivation of functional mature neutrophils from human embryonic stem cells
Blood,
June 25, 2009;
113(26):
6584 - 6592.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Pearson, P. Sroczynska, G. Lacaud, and V. Kouskoff
The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF
Development,
April 15, 2008;
135(8):
1525 - 1535.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. S. Woll, J. K. Morris, M. S. Painschab, R. K. Marcus, A. D. Kohn, T. L. Biechele, R. T. Moon, and D. S. Kaufman
Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells
Blood,
January 1, 2008;
111(1):
122 - 131.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. de Wert, I. Liebaers, and H. Van de Velde
The Future (R)evolution of Preimplantation Genetic Diagnosis/Human Leukocyte Antigen Testing: Ethical Reflections
Stem Cells,
September 1, 2007;
25(9):
2167 - 2172.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Pick, L. Azzola, A. Mossman, E. G. Stanley, and A. G. Elefanty
Differentiation of Human Embryonic Stem Cells in Serum-Free Medium Reveals Distinct Roles for Bone Morphogenetic Protein 4, Vascular Endothelial Growth Factor, Stem Cell Factor, and Fibroblast Growth Factor 2 in Hematopoiesis
Stem Cells,
September 1, 2007;
25(9):
2206 - 2214.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Krtolica, O. Genbacev, C. Escobedo, T. Zdravkovic, A. Nordstrom, D. Vabuena, A. Nath, C. Simon, K. Mostov, and S. J. Fisher
Disruption of Apical-Basal Polarity of Human Embryonic Stem Cells Enhances Hematoendothelial Differentiation
Stem Cells,
September 1, 2007;
25(9):
2215 - 2223.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Srivastava, E. Nedelcu, B. Esmaeli-Azad, R. Mishra, and E. Carrier
Thrombopoietin Enhances Generation of CD34+ Cells from Human Embryonic Stem Cells
Stem Cells,
June 1, 2007;
25(6):
1456 - 1461.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Cervi, Y. Shaked, M. Haeri, T. Usenko, C. R. Lee, J. J. Haigh, A. Nagy, R. S. Kerbel, E. Yefenof, and Y. Ben-David
Enhanced natural-killer cell and erythropoietic activities in VEGF-A-overexpressing mice delay F-MuLV-induced erythroleukemia
Blood,
March 1, 2007;
109(5):
2139 - 2146.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Bhatia
Hematopoietic Development from Human Embryonic Stem Cells
Hematology,
January 1, 2007;
2007(1):
11 - 16.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K.-H. Chang, A. M. Nelson, H. Cao, L. Wang, B. Nakamoto, C. B. Ware, and T. Papayannopoulou
Definitive-like erythroid cells derived from human embryonic stem cells coexpress high levels of embryonic and fetal globins with little or no adult globin
Blood,
September 1, 2006;
108(5):
1515 - 1523.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. M. Bowles, L. Vallier, J. R. Smith, M. R. J. Alexander, and R. A. Pedersen
HOXB4 Overexpression Promotes Hematopoietic Development by Human Embryonic Stem Cells
Stem Cells,
May 1, 2006;
24(5):
1359 - 1369.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Umeda, T. Heike, M. Yoshimoto, G. Shinoda, M. Shiota, H. Suemori, H. Y. Luo, D. H. K. Chui, R. Torii, M. Shibuya, et al.
Identification and Characterization of Hemoangiogenic Progenitors During Cynomolgus Monkey Embryonic Stem Cell Differentiation
Stem Cells,
May 1, 2006;
24(5):
1348 - 1358.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Tian, P. S. Woll, J. K. Morris, J. L. Linehan, and D. S. Kaufman
Hematopoietic Engraftment of Human Embryonic Stem Cell-Derived Cells Is Regulated by Recipient Innate Immunity
Stem Cells,
May 1, 2006;
24(5):
1370 - 1380.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Trounson
The Production and Directed Differentiation of Human Embryonic Stem Cells
Endocr. Rev.,
April 1, 2006;
27(2):
208 - 219.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Priddle, D. R. E. Jones, P. W. Burridge, and R. Patient
Hematopoiesis from Human Embryonic Stem Cells: Overcoming the Immune Barrier in Stem Cell Therapies
Stem Cells,
April 1, 2006;
24(4):
815 - 824.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. W. Lensch and G. Q. Daley
Scientific and clinical opportunities for modeling blood disorders with embryonic stem cells
Blood,
April 1, 2006;
107(7):
2605 - 2612.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. S. Woll, C. H. Martin, J. S. Miller, and D. S. Kaufman
Human Embryonic Stem Cell-Derived NK Cells Acquire Functional Receptors and Cytolytic Activity
J. Immunol.,
October 15, 2005;
175(8):
5095 - 5103.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. T. Zambidis, B. Peault, T. S. Park, F. Bunz, and C. I. Civin
Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development
Blood,
August 1, 2005;
106(3):
860 - 870.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Wang, L. Li, P. Menendez, C. Cerdan, and M. Bhatia
Human embryonic stem cells maintained in the absence of mouse embryonic fibroblasts or conditioned media are capable of hematopoietic development
Blood,
June 15, 2005;
105(12):
4598 - 4603.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Keller
Embryonic stem cell differentiation: emergence of a new era in biology and medicine
Genes & Dev.,
May 15, 2005;
19(10):
1129 - 1155.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Carotta, S. Pilat, A. Mairhofer, U. Schmidt, H. Dolznig, P. Steinlein, and H. Beug
Directed differentiation and mass cultivation of pure erythroid progenitors from mouse embryonic stem cells
Blood,
September 15, 2004;
104(6):
1873 - 1880.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Park, I. Afrikanova, Y. S. Chung, W. J. Zhang, E. Arentson, G. h. Fong, A. Rosendahl, and K. Choi
A hierarchical order of factors in the generation of FLK1- and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells
Development,
June 1, 2004;
131(11):
2749 - 2762.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
